Please provide your email address to receive an email when new articles are posted on . scPharmaceuticals Inc. announced the FDA approved its self-administered subcutaneous furosemide injection for ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication of self-administered subcutaneous furosemide for patients with HF. The ...

CIBA, JAPAN — For acute heart failure (HF) patients arriving in the emergency department (ED), administration of intravenous (IV) furosemide within 1 hour is independently associated with lower ...

The US Food and Drug Administration (FDA) has approved a furosemide preparation (Furoscix, scPharmaceuticals) intended for subcutaneous self-administration by outpatients with chronic heart failure ...

You cannot be reimbursed in advance for any services. Because FSA funds are available to you on the first day of your plan year, you must be able to receive full reimbursement for your contribution.

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Furosemide for Injection in the ...

The U.S. Food and Drug Administration has approved Lasix ONYU, an at-home version of the common heart failure drug Lasix The device allows safe treatment for fluid buildup without hospital IV infusion ...

HealthDay News — Intravenous (IV) diuretics appear to be safe and effective for outpatient volume management in heart failure, according to a study published online December 2 in JACC: Heart Failure.

(HealthDay News) — Intravenous (IV) diuretics appear to be safe and effective for outpatient volume management in heart failure, according to a study published online in JACC: Heart Failure. Leo F.

Furosemide oral tablet is a prescription drug used to treat high blood pressure in adults. It can also be prescribed for edema (fluid buildup) related to congestive heart failure, kidney disease, and ...

FUROSCIX ReadyFlow Autoinjector Could Transform Care from Hours to Seconds MannKind recently announced that the FDA accepted for review its sNDA for the FUROSCIX ReadyFlow Autoinjector for the ...